Combinent Biomedical Systems Company

Combinent Biomedical Systems focuses on the transvaginal delivery of drugs targeting women's reproductive endocrinology disorders.

Investors

Total Funding: $6 350 000
Headquarters: Lexington, Massachusetts, United States
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown
Last Funding Date: 2012-10-02
Founded Date: 2000-01-01
Industry: Sexual Healthcare
Register and Claim Ownership